Carlisle Companies Incorporated (CSL) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Carlisle Companies Incorporated  (NYSE: CSL)


Carlisle Companies Incorporated's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Carlisle Companies Incorporated's ROI in the second quarter of 2026?
Carlisle Companies Incorporated achieved a return on average invested assets (ROI) of 20.71 % in its second quarter of 2026, this is above CSL's average return on investment of 11.94%.
Carlisle Companies Incorporateds investments during the 12 months ending in the second quarter of 2026 are valued at $3 billion

ROI fell compared to the first quarter of 2026, despite the net income growth of 99.84% from the first quarter of 2026.

Within the Healthcare sector 57 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 232 to 235.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 9.49 % -33.25 % -48.8 % -44.42 % -37.24 %
Y / Y Net Income Change TTM -10.13 % -42.58 % -33.84 % -18.88 % 13.17 %
Investment (TTM) in Millions 5,351 2,884 2,882 2,879 1,892
Return On Investment (TTM) 20.71 % 27.53 % 31.05 % 28.19 % 25.23 %
CSL's Overall Ranking # 235 # 232 # 67 # 53 # 72
Seq. Investment Change TTM 32.84 % 10.41 % -13.34 % -13.86 % -19.01 %
Seq. Net Income Change TTM -0.08 % -2.11 % -4.56 % -3.73 % -36.16 %
Net Income (TTM) in Millions 725 725 741 776 806

CSL Company Profile >> Back to CSL Roi Comparisons >> See Annual CSL Return On Investment



Return On Investment CSL's Ranking
Within: No.
Industry # 11
Sector # 58
Overall # 235

Return On Investment Statistics
High Average Low
29.62 %
11.94 %
6.01 %
  (Mar 31 2021)







Financial Statements
Carlisle Companies Incorporated's II. Quarter Investments $ 5,351 Millions CSL's Balance sheet
Carlisle Companies Incorporated's II. Quarter Income $ 255 Millions Quarterly CSL's Income Statement
CSL's Income by Division See CSL's Income by Division


CSL Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 2,882 4,351 5,525 5,306 5,827
Y / Y Investment Growth -33.77 % -21.25 % 4.12 % -8.95 % 16.91 %
Net Income in Millions 741 1,312 766 924 422
Y / Y Net Income Growth -43.54 % 71.34 % -17.14 % 119.11 % 31.74 %
Annual Return On Investment 25.7 % 30.15 % 13.86 % 17.41 % 7.24 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 25.7 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CSL's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CSL's Competitors
Subscribers only: Roi for Carlisle Companies Incorporated's Suppliers
Subscribers only: Return On Investment for CSL's Customers

Other Ratios
CSL's Roa CSL's Inventory Turnover Ratio CSL's Growth Rates CSL's Dividend Statistics
CSL's Profitability Ratios CSL's Asset Turnover Ratio CSL's Dividend Growth
CSL's Roe CSL's Valuation Ratios CSL's Financial Strength Ratios CSL's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Meiragtx Holdings Plc  55.83 %
Elite Pharmaceuticals Inc   53.48 %
Idexx Laboratories Inc  51.80 %
Aurinia Pharmaceuticals Inc   50.35 %
Qhslab Inc   48.94 %
Q32 Bio Inc   47.43 %
Vaxart Inc   46.17 %
Liquidia Corporation  42.09 %
Tg Therapeutics Inc   39.26 %
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %

Date modified: 2026-09-14T03:51:12+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.